Vyvanse (lisdexamfetamine) is a new medication for ADD and ADHD, which is currently approved for ADHD in children, aged 6-12. Shire, the makers of Vyvanse, have applied to the FDA for approval for Vyvanse to be indicated in Adults.
Discuss Share This Tell a friendDiscard Add to:
| |
| Bookmarks